Research
Energy balance
TZP significantly decreased food intake during lunch and dinner compared to PBO.
TZP may help reduce overall food consumption in individuals with obesity.
StrongSupportsmedium confidence
TZP significantly decreased food intake from baseline during lunch (-285±42 kcal) and dinner (-631±58 kcal) compared to PBO (60± 42, and -116±58 kcal, respectively).
Why this rating
Based on a randomized blinded clinical trial design.
Source
128-OR: The Effect of Tirzepatide during Weight Loss on Food Intake, Appetite, Food Preference, and Food Craving in People with Obesity
CORBY K. MARTIN et al. · Diabetes · 2023
rct · n=55Cited 20×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →